tak 779 has been researched along with rs 504393 in 1 studies
Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (rs 504393) | Trials (rs 504393) | Recent Studies (post-2010) (rs 504393) |
---|---|---|---|---|---|
118 | 1 | 35 | 32 | 0 | 29 |
Protein | Taxonomy | tak 779 (IC50) | rs 504393 (IC50) |
---|---|---|---|
C-C chemokine receptor type 2 | Homo sapiens (human) | 0.089 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkhout, TA; Blaney, FE; Bridges, AM; Cooper, DG; Forbes, IT; Gribble, AD; Groot, PH; Hardy, A; Ife, RJ; Kaur, R; Moores, KE; Shillito, H; Willetts, J; Witherington, J | 1 |
1 other study(ies) available for tak 779 and rs 504393
Article | Year |
---|---|
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
Topics: Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; Cattle; Cell Line; Chemotaxis; CHO Cells; Cricetinae; Humans; Indoles; Kinetics; Models, Molecular; Monocytes; Mutagenesis, Site-Directed; Piperidines; Radioligand Assay; Receptors, CCR2; Receptors, Chemokine; Recombinant Proteins; Rhodopsin; Structural Homology, Protein; Transfection | 2003 |